La Jolla Pharmaceutical Company 401(k) Profit Sharing Plan and Trust

401(k) · DOL Form 5500 · 2022

What the Filing Says About La Jolla Pharmaceutical Company 401(k) Profit Sharing Plan and Trust

La Jolla Pharmaceutical Company 401(k) Profit Sharing Plan and Trust is a 401(k) retirement plan sponsored by La Jolla Pharmaceutical Company, headquartered in Massachusetts. According to the U.S. Department of Labor's 2022 Form 5500 filing, the plan reports $20M in total end-of-year assets and covers 71 participants across the Professional & Technical Services industry. The sponsor's EIN on file with the U.S. Department of Labor is 330361285, and the plan has been effective since 2010-09-01. Its filing status is currently FILING RECEIVED.

Year over year, total assets declined sharply from $26M at the beginning of 2022 to $20M at year-end - down 24.1%. Net assets (after liabilities) closed the year at $20M, with reported net income of -$6M driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return.

By assets, La Jolla Pharmaceutical Company 401(k) Profit Sharing Plan and Trust outranks 77% of the 139,258 plans that filed a Form 5500 for the 2022 plan year, and holds roughly 0.2x the national average plan size of $100M and 730 average participants.

Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows, a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.

How the percentile is calculated: we count every plan that filed a 2022 Form 5500 with a reported end-of-year asset figure (139,258 plans), rank La Jolla Pharmaceutical Company 401(k) Profit Sharing Plan and Trust against all of them by total assets, and report the share of those plans it outranks. A plan reporting no asset figure for the year is excluded from the ranking rather than assumed to be zero.